Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis

YINA ZHANG, XIAOCEN NIU, YUANHE WANG, SHUTING BAO, PEIYUE JIANG and XIAORUI DONG
Anticancer Research July 2024, 44 (7) 2861-2870; DOI: https://doi.org/10.21873/anticanres.17098
YINA ZHANG
Women’s Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
XIAOCEN NIU
Women’s Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUANHE WANG
Women’s Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUTING BAO
Women’s Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PEIYUE JIANG
Women’s Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
XIAORUI DONG
Women’s Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 5511012{at}zju.edu.cn
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 44 (7)
Anticancer Research
Vol. 44, Issue 7
July 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis
YINA ZHANG, XIAOCEN NIU, YUANHE WANG, SHUTING BAO, PEIYUE JIANG, XIAORUI DONG
Anticancer Research Jul 2024, 44 (7) 2861-2870; DOI: 10.21873/anticanres.17098

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis
YINA ZHANG, XIAOCEN NIU, YUANHE WANG, SHUTING BAO, PEIYUE JIANG, XIAORUI DONG
Anticancer Research Jul 2024, 44 (7) 2861-2870; DOI: 10.21873/anticanres.17098
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • DNA Damage-induced Post-transcriptional Regulation of SIRT4 by the miR-15/16 Family Modulates Chemosensitivity in Cancer Cells
  • Google Scholar

More in this TOC Section

  • Over-expression of Paternally Expressed Gene 10 (PEG10) Is Associated With Poor Prognosis in Upper Tract Urothelial Carcinomas
  • Gallic Acid as a Non-cytotoxic Modulator of the ROS–EGFR–ERK–EMT Axis in Xenograft-derived T98G Glioblastoma Cells
  • Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure
Show more Experimental Studies

Keywords

  • SIRT4
  • Cervical cancer
  • MEK/ERK/c-myc signal
  • glutamine metabolism
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire